Exhibiting at the ASH annual meeting puts your organization in front of physicians and others with a specific interest in hematology, ensuring that your products and services will be exposed to a highly targeted audience. As illustrated below, meeting attendees include both clinicians and researchers from all branches of hematology and from all over the world. (For a list of last year’s exhibitors, please see 2008 Exhibitors.)
ASH Annual Meeting Attendance
Year
|
Location
|
Attendance
|
| 2008 |
San Francisco, CA |
24,032 |
| 2007 |
Atlanta, GA |
20,474 |
| 2006 |
Orlando, FL |
20,748 |
| 2005 |
Atlanta, GA |
18,683 |
The following figures exclude exhibitors and guests.
Primary Institutional Affiliation
Hospital/Clinical Facility
|
30%
|
Medical School
|
28%
|
Corporate (Biotech or Pharmaceutical)
|
19%
|
Nonprofit Research Institute
|
7%
|
Private Practice
|
6%
|
Corporate Research Institute
|
3%
|
Free-Standing Health-Care Facility
|
0%
|
Other
|
7%
|
Geographic Breakdown
| United States |
8,868 |
| International |
11,050 |
| Europe |
6,442 |
| Asia |
1,940 |
| South America,Central America, and Caribbean |
1,174 |
| Canada |
819 |
| Africa |
154 |
| Mexico |
267 |
| Australia |
254 |
| Total |
19,918 |
Primary Job Responsibilities
| Research |
33%
|
Direct or Lab-Based Patient Care
|
28%
|
Teaching
|
17%
|
Administration
|
12%
|
Other
|
10%
|
Primary Subspecialty Area
| Internal Medicine |
56% |
| Hematology-Oncology |
53% |
| Hematology |
32% |
| Oncology |
8% |
| Transfusion Medicine |
1% |
| Other |
6% |
| Research Scientist |
29% |
| Hematology |
29% |
| Oncology |
24% |
| Biochemistry/Molecular Biology |
17% |
| Immunology/Microbiology |
9% |
| Pharmacology |
4% |
| Cell Biology |
7% |
| Biophysics/Physiology |
1% |
| Other |
9% |
| Pediatrics |
10% |
| Hematology-Oncology |
68% |
| Hematology |
21% |
| Oncology |
6% |
| Other |
5% |
| Pathology |
5% |
| Hematopathology |
50% |
| Laboratory Medicine |
30% |
| Transfusion Medicine |
15% |
| Other |
5% |
back to top